BioSpace News Archive

Seagen Inc. announced that management will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022 at 3:00 p.m. Eastern Time.

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced that William J. Link, Ph.D., will be retiring as Chairman of the Board, effective December 31, 2021.

Ocugen, Inc. announced the Compensation Committee of the Board of Directors of Ocugen approved the grant of stock options to purchase an aggregate of 6,750 shares of its common stock and restricted stock units covering an aggregate of 1,150 shares of common stock to one newly hired team member.

Breakthrough research has now revealed the true crystal forms of pharmaceutical psilocybin. A new study overcomes experimental challenges to solve the crystallographic puzzle and brings clarity to the unique crystalline arrangements, called polymorphs, that naturally arise from the production of synthetic psilocybin.

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. (Pfizer) and Shionogi Limited (Shionogi) as shareholders, today announced that the US Food and Drug Administration (FDA) approved Apretude, the first and only long-acting injectable pre-exposure prophylaxis (PrEP) option to reduce the risk of sexually acquired HIV-1.

Deficiency of Vitamin D is a common issue faced by many across the globe. It is more common amongst the older adults.

Recombinant trypsin is a genetically engineered protein that is developed for the effective separation of adherent cell types from tissues and culture surfaces.

Fact.MR – A Market Research and Competitive Intelligence Provider: The global denture disinfectants market is projected to reach US$ 515 Mn over the forecast period from 2019 to 2029.

Infusion therapy is commonly utilized to treat cancers of many types, gastrointestinal disorders, and diabetes.

Fact.MR – A Market Research and Competitive Intelligence Provider: The global ambulance cots market size is expected to reach US$ 273 Mn, with sales projected to increase by 1.3x from 2019 to 2029, predicts Fact.MR.